MedTrace Logo

Probing Gut-Brain Communication in Parkinson's Disease

NCT07673146 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2026-07-02

No results posted yet for this study

Summary

Administering transcutaneous vagus nerve stimulation in patients with Parkinson's disease to see how it affects stomach and brain activity.

Conditions

  • Parkinson Disease (PD)

Interventions

DEVICE

taVNS

Active taVNS delivered to the external ear at a moderate, non-painful level.

DEVICE

Sham taVNS

Sham taVNS delivered to the external ear using zero-current.

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Spaulding Rehabilitation Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-01
Primary Completion
2031-07-01
Completion
2031-07-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07673146 on ClinicalTrials.gov